Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

PMI vs KIDS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PMI Captures Overall Composite Edge (48.4 HOLD vs 45.1 HOLD), While KIDS Leads 4–1 on Growth & Valuation Pillars

PMI Overall Winner 6-Pillar Tally: PMI 1 – 4 KIDS (1 Tie) Matrix Metrics: PMI 5 – 4 KIDS

As of Nov 19, 2026, Picard Medical, Inc. (PMI) captures the overall head-to-head institutional edge over OrthoPediatrics Corp. (KIDS) on higher Unified Composite conviction (48.4/100 HOLD vs. 45.1/100 HOLD) after splitting the core matrix 5–4 (led by Valuation Multiples), while KIDS wins 4–1 across the 6-pillar growth and valuation breakdown. PMI trades at $6.30 (N/M Forward P/E, -248.1% operating margin) versus KIDS at $32.51 (N/M Forward P/E, -8.2% operating margin).

  • Growth vs. Quality Trade-Off: PMI earns the overall head-to-head edge with a stronger Unified Composite Score (48.4/100 HOLD vs. KIDS 45.1/100 HOLD) and 54.06β · 134% Vol risk profile, whereas KIDS leads top-line expansion (+18.6% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PMI vs KIDS
PMI NYSE American Head-to-Head Winner
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap $17.1M
TTM Revenue $6.3M
Forward P/E N/M
Beta / 30D Vol 54.06β · 134% Vol
Unified Composite Score
48.4 / 100 HOLD
Tech 39.0 Fund 45.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 42
RSI-14: 42.1 · SMA20: $7.55 · SMA50: $7.62
KIDS NASDAQ
OrthoPediatrics Corp. Common Stock
Surgical & Medical Instruments & Apparatus
$32.51
+2.72% 1D
Market Cap $850.2M
TTM Revenue $264M
Forward P/E N/M
Beta / 30D Vol 0.81β · 108% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 28.0 Fund 40.0 Flow 50.0 Mom 46.3
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (12.1% over 20 days), RSI 64
RSI-14: 64.2 · SMA20: $30.90 · SMA50: $25.86

6-Pillar Scorecard Institutional Category Breakdown (PMI 1 – 4 KIDS)

Columns: Metric · PMI · KIDS
1. Valuation Multiples PMI
Forward P/E N/M N/M
Trailing P/E 2.9x N/M
PEG Ratio N/M N/M
EV / Revenue 3.2x 3.2x
2. Growth & Scale KIDS
Revenue Growth (YoY) +38.6% +18.6%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $6.3M $264M
Market Cap $17.1M $850.2M
3. Profitability & Quality KIDS
Gross Margin 18.6% 73.8%
Operating Margin -248.1% -8.2%
Net Profit Margin 0.0% -12.8%
Return on Equity (ROE) 0.0% -9.8%
4. Balance Sheet & Cash Flow KIDS
Cash Generation (TTM) -$17M $1.1M EBITDA
Cash Flow Margin N/A 0.4% EBITDA Mgn
Net Cash / Leverage $3.2M Net Debt $12.99 Book/Sh · -9.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 145.1% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat KIDS
OpEx & R&D Intensity N/A 82.0% of Rev ($217M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PMI (5) vs KIDS (4)
Institutional Metric PMI KIDS Criterion Row Edge
Market Capitalization
Scale
$17.1M $850.2M Larger Scale KIDS
Trailing P/E Ratio
Valuation
2.9x N/M Lower Multiple PMI
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+38.6% +18.6% Higher Growth PMI
Operating Margin (TTM)
Profitability
-248.1% -8.2% Higher Margin KIDS
Net Profit Margin
Profitability
0.0% -12.8% Higher Margin PMI
Return on Equity (ROE)
Capital Efficiency
0.0% -9.8% Higher ROE PMI
52-Week Range Position
Momentum
34% ($0–$18) 90% ($14–$35) Stronger Trend KIDS
Beta / 30D Volatility
Risk Regime
54.06β · 134% Vol 0.81β · 108% Vol Lower Realized Risk KIDS
Unified Institutional Score
Composite Signal
48.4 / 100 (HOLD) 45.1 / 100 (HOLD) Higher Composite PMI
Trailing 12M Revenue (USD)
Operating Scale
$6.3M $264M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
18.6% 73.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.2x EV/Rev N/M PEG · 3.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$17M ($3.2M Net Debt) $1.1M EBITDA ($12.99 Book/Sh · -9.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KIDS +70.95 pp
PMI: -34.58% · KIDS: +36.37%
3M Horizon PMI +69.52 pp
PMI: +96.26% · KIDS: +26.74%
6M Horizon PMI +3355.86 pp
PMI: +3439.33% · KIDS: +83.47%
1Y Horizon PMI +49.19 pp
PMI: +148.03% · KIDS: +98.84%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PMI vs KIDS. Trailing 12-month operating profitability (PMI -248.1% vs KIDS -8.2%) and valuation multiples (PMI N/M vs KIDS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

PMI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$6.3M
Gross Margin18.6%
Op. Margin-248.1%
ROE / Fwd P/E0.0% · N/M
KIDS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$264M
Gross Margin73.8%
Op. Margin-8.2%
ROE / Fwd P/E-9.8% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PMI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PMI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
KIDS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 145.1%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KIDS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PMI Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $17.1M market capitalization and -248.1% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
KIDS Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $850.2M market capitalization and -8.2% operating margin.
OpEx & R&D Reinvestment 82.0% of Rev ($217M)
90D Engineering Disclosures 0 Published

Investor FAQ PMI vs KIDS Key Questions & Quantitative Answers

As of Nov 19, 2026, Picard Medical, Inc. (PMI) captures the overall head-to-head institutional edge over OrthoPediatrics Corp. (KIDS) on higher Unified Composite conviction (48.4/100 HOLD vs. 45.1/100 HOLD) after splitting the core matrix 5–4 (led by Valuation Multiples), while KIDS wins 4–1 across the 6-pillar growth and valuation breakdown. PMI trades at $6.30 (N/M Forward P/E, -248.1% operating margin) versus KIDS at $32.51 (N/M Forward P/E, -8.2% operating margin). Growth vs. Quality Trade-Off: PMI earns the overall head-to-head edge with a stronger Unified Composite Score (48.4/100 HOLD vs. KIDS 45.1/100 HOLD) and 54.06β · 134% Vol risk profile, whereas KIDS leads top-line expansion (+18.6% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.

KIDS leads the Growth & Scale pillar: PMI posts +38.6% YoY revenue growth and +0.0% YoY earnings growth on $6.3M TTM revenue (18.6% gross margin, -248.1% operating margin), compared with KIDS at +18.6% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (73.8% gross margin, -8.2% operating margin). On trailing 12-month operating scale, PMI generates $6.3M in USD-normalized revenue versus $264M for KIDS. In operating R&D and SG&A reinvestment, PMI deploys N/A (0 90-day corporate R&D disclosures) versus 82.0% of Rev ($217M) (0 disclosures) for KIDS.

PMI screens cheaper on headline valuation multiples. PMI trades at N/M Forward P/E, 2.9x Trailing P/E, N/M PEG, and 3.2x EV/Revenue (unreported FCF margin), whereas KIDS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (0.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PMI (0.0% ROE) versus KIDS (-9.8% ROE) capital efficiency.

In options market volatility and institutional positioning, PMI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (54.06β · 134% Vol realized risk). By comparison, KIDS carries 145.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 108% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.